174 related articles for article (PubMed ID: 21561896)
1. Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease.
Read PA; Khan FZ; Dutka DP
Heart; 2012 Mar; 98(5):408-13. PubMed ID: 21561896
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
[TBL] [Abstract][Full Text] [Related]
3. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.
Read PA; Khan FZ; Heck PM; Hoole SP; Dutka DP
Circ Cardiovasc Imaging; 2010 Mar; 3(2):195-201. PubMed ID: 20075143
[TBL] [Abstract][Full Text] [Related]
4. Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease.
McCormick LM; Kydd AC; Read PA; Ring LS; Bond SJ; Hoole SP; Dutka DP
Circ Cardiovasc Imaging; 2014 Mar; 7(2):274-81. PubMed ID: 24503784
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humans.
Read PA; Hoole SP; White PA; Khan FZ; O'Sullivan M; West NE; Dutka DP
Circ Cardiovasc Interv; 2011 Jun; 4(3):266-72. PubMed ID: 21586690
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.
Giblett JP; Axell RG; White PA; Clarke SJ; McCormick L; Read PA; Reinhold J; Brown AJ; O'Sullivan M; West NE; Dutka DP; Hoole SP
Cardiovasc Diabetol; 2016 Jul; 15():99. PubMed ID: 27431258
[TBL] [Abstract][Full Text] [Related]
7. Stress echocardiography: abnormal response of tissue Doppler-derived indices to dobutamine in the absence of obstructive coronary artery disease in patients with chronic renal failure.
Jassal DS; Neilan TG; Picard MH; Wood MJ
Echocardiography; 2007 Jul; 24(6):580-6. PubMed ID: 17584197
[TBL] [Abstract][Full Text] [Related]
8. Tissue velocity imaging with dobutamine stress echocardiography--a quantitative technique for identification of coronary artery disease in patients with left bundle branch block.
Badran HM; Elnoamany MF; Seteha M
J Am Soc Echocardiogr; 2007 Jul; 20(7):820-31. PubMed ID: 17617308
[TBL] [Abstract][Full Text] [Related]
9. Dobutamine-induced myocardial ischemia and ST-segment elevation in collateral-dependent myocardium.
Shirani J; Pranesh S; Menhaji K; Cotarlan V; Brofferio A
Am J Cardiol; 2013 Nov; 112(9):1293-7. PubMed ID: 23866734
[TBL] [Abstract][Full Text] [Related]
10. Assessment of global left ventricular excursion using three-dimensional dobutamine stress echocardiography to identify significant coronary artery disease.
Hoogslag GE; Joyce E; Bax JJ; Ajmone Marsan N; Delgado V
Echocardiography; 2016 Oct; 33(10):1532-1538. PubMed ID: 27307310
[TBL] [Abstract][Full Text] [Related]
11. [Coronary artery spasm during dobutamine stress echocardiography: prevalence, clinical and echocardiographic characteristics and prognosis].
Aboukhoudir F; Rekik S; Andrieu S; Cheggour S; Metge M; Hirsch JL; Barnay P; Faugier JP; Gonzalez S; Aboukhoudir I; Gonthier C; Klioua Y; Pansieri M
Ann Cardiol Angeiol (Paris); 2012 Nov; 61(5):311-6. PubMed ID: 22959441
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of ultrasonic regional strain and strain rate imaging in quantifying dobutamine stress echocardiography.
Kowalski M; Herregods MC; Herbots L; Weidemann F; Simmons L; Strotmann J; Dommke C; D'hooge J; Claus P; Bijnens B; Hatle L; Sutherland GR
Eur J Echocardiogr; 2003 Jun; 4(2):81-91. PubMed ID: 12749869
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
McCormick LM; Hoole SP; White PA; Read PA; Axell RG; Clarke SJ; O'Sullivan M; West NEJ; Dutka DP
JACC Cardiovasc Interv; 2015 Feb; 8(2):292-301. PubMed ID: 25700752
[TBL] [Abstract][Full Text] [Related]
14. Diabetes as an independent predictor of left ventricular longitudinal strain reduction at rest and during dobutamine stress test in patients with significant coronary artery disease.
Wierzbowska-Drabik K; Trzos E; Kurpesa M; Rechcinski T; Miskowiec D; Cieslik-Guerra U; Uznanska-Loch B; Sobczak M; Kasprzak JD
Eur Heart J Cardiovasc Imaging; 2018 Nov; 19(11):1276-1286. PubMed ID: 29236974
[TBL] [Abstract][Full Text] [Related]
15. Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.
Zaglavara T; Haaverstad R; Cumberledge B; Irvine T; Karvounis H; Parharidis G; Louridas G; Kenny A
Heart; 2002 Apr; 87(4):329-35. PubMed ID: 11907003
[TBL] [Abstract][Full Text] [Related]
16. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.
Kumarathurai P; Anholm C; Nielsen OW; Kristiansen OP; Mølvig J; Madsbad S; Haugaard SB; Sajadieh A
Cardiovasc Diabetol; 2016 Jul; 15(1):105. PubMed ID: 27455835
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the tissue Doppler, strain rate, strain imaging during the dobutamine infusion and coronary fractional flow reserve during catheterization: a comparative study.
Dagdelen S; Yuce M; Emiroglu Y; Ergelen M; Pala S; Tanalp AC; Izgi A; Kirma C
Int J Cardiol; 2005 Jun; 102(1):127-36. PubMed ID: 15939109
[TBL] [Abstract][Full Text] [Related]
18. Persistent dysfunction of viable myocardium after revascularization in chronic ischaemic heart disease: implications for dobutamine stress echocardiography with longitudinal systolic strain and strain rate measurements.
Rösner A; Avenarius D; Malm S; Iqbal A; Baltabaeva A; Sutherland GR; Bijnens B; Myrmel T
Eur Heart J Cardiovasc Imaging; 2012 Sep; 13(9):745-55. PubMed ID: 22379128
[TBL] [Abstract][Full Text] [Related]
19. Quantitative approach using multiple single parameters versus visual assessment in dobutamine stress echocardiography.
Celutkiene J; Zakarkaite D; Skorniakov V; Zvironaite V; Grabauskiene V; Burca J; Ciparyte L; Laucevicius A
Cardiovasc Ultrasound; 2012 Jul; 10():31. PubMed ID: 22846395
[TBL] [Abstract][Full Text] [Related]
20. Relation between ischaemic threshold measured during dobutamine stress echocardiography and coronary angiographic features.
Shehata M
Kardiol Pol; 2014; 72(12):1380-7. PubMed ID: 24846365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
